Brightspring Health Services Inc (BTSG) Stock Analysis
Verdict: WATCH (do not buy)
Specialty pharmacy expansion drives double-digit top-line growth, but razor-thin 3.3% operating margins and PE overhang cap upside.
Investment score: 56/100
Analysis as of
Is Brightspring Health Services Inc stock worth reviewing? The TradeMates thesis
BrightSpring Health demonstrates solid 19.9% top-line expansion and positive cash flow momentum, but elevated debt levels and major PE insider selling warrant patience before building new long positions.
7-factor investment score
- Valuation: 45/100 (weight 20%)
- Financial Health: 60/100 (weight 15%)
- Technical Momentum: 50/100 (weight 15%)
- Earnings Quality: 75/100 (weight 15%)
- Insider Sentiment: 25/100 (weight 10%)
- Analyst Consensus: 85/100 (weight 10%)
- Risk-Adjusted Return: 55/100 (weight 15%)
Brightspring Health Services Inc opportunities and risks
What speaks for BTSG
- 30% Specialty Pharmacy and Infusion Segment Growth
What speaks against BTSG
- Private Equity Overhang and Institutional Insider Liquidations
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| BTSG | 41.2x | 0.8x | 21.0x | 12.4% | 2.0% | 3.5% |
| DGX | 25.9x | 2.4x | 16.4x | 33.1% | 9.2% | 4.5% |
| LH | 26.7x | 1.9x | 15.4x | 27.8% | 7.0% | 4.3% |
| GH | n/a | 19.8x | n/a | 65.0% | -38.3% | -1.0% |
| LH | 26.7x | 1.9x | 15.4x | 27.8% | 7.0% | 4.3% |
| DVA | 16.7x | 0.9x | 8.2x | 31.0% | 6.0% | 12.9% |
| Peer median | 25.9x | 1.9x | 15.4x | 31.0% | 7.0% | 4.3% |
Frequently asked questions about Brightspring Health Services Inc (BTSG)
Is BTSG stock a good investment?
The TradeMates model rates Brightspring Health Services Inc as WATCH (do not buy) with an investment score of 56/100. BrightSpring Health demonstrates solid 19.9% top-line expansion and positive cash flow momentum, but elevated debt levels and major PE insider selling warrant patience before building new long positions. This is algorithmic model output, not personal investment advice.
Is BTSG stock a buy?
The TradeMates model verdict for BTSG is WATCH (do not buy) with an investment score of 56/100. Treat this as a model signal to review, not a personal buy recommendation.